Midi Health is democratizing healthcare at every stage.
What’s happening: The women’s telehealth company secured a $100M Series D led by Goodwater Capital, with participation from Serena Williams’ Serena Ventures and more.
Adding to a recent $50M raise, Midi will leverage its $1B+ valuation and AI-equipped platform to provide care for women of all ages.
Midlife model. Addressing fragmentation in women’s health, Midi provides insurance-covered perimenopause and menopause care across 50 states. Deeply integrated, Midi’s virtual visits span dermatology, cardiology, and care for obesity, sleep, and mood changes, prescribing solutions like HRT, weight loss drugs, skincare topicals, and own-brand supplements.
All stages. Currently treating >25K patients weekly, Midi will extend its care beyond midlife, according to Midi Health co-founder and CEO Joanna Strober:
“Women’s health has been treated like an afterthought for too long. This funding gives us the resources to rewrite that story at scale.”
Scaling its consumer base, Midi will introduce additional pathways for metabolic health, weight management, and MSK health while investing in AI for backend efficiency, research analysis, and patient personalization.
Looking ahead: Midi is growing with its consumers, adopting a higher, gender-informed standard to become a one-stop shop for women’s health.
